The Collaboration aims to scale production of innovative UV Balloon Catheter designed to reduce side effects of ischemic stroke & other cardiovascular conditions
OAKLAND PARK, FL / ACCESS Newswire / February 21, 2025 / EndoUVtech, an innovative medical device company committed to improving outcomes for ischemic stroke patients and other cardiovascular conditions, today announced a manufacturing agreement with a leading global provider of medical technologies. Under the agreement, the global partner will leverage its extensive manufacturing capabilities to produce EndoUVtech's proprietary UV Balloon Catheter - an essential component of the company's Smart UV Laser system.
"This collaboration marks a pivotal moment for EndoUVtech," said Chip Van Vurst, CEO of EndoUVtech. "Our partner's extensive experience in manufacturing medical devices, along with their strong global reputation, makes them the ideal choice for our UV balloon catheter needs. Our Smart UV Laser system represents a significant step forward in endovascular treatment by minimizing tissue damage and helping dissolve downstream clots. This technology has the potential to reduce the side effects of ischemic stroke and become a new standard of care worldwide."
"We look forward to working closely with our new manufacturing partner to bring this breakthrough solution to clinicians and patients globally," Van Vurst continued. "By combining our expertise in UV-based therapies with their robust production capabilities, we're poised to enhance treatment outcomes for stroke and other cardiovascular conditions."
Large-scale production of the UV Balloon Catheter is expected to begin in the coming months, subject to applicable regulatory clearances. EndoUVtech plans to introduce its Smart UV Laser system in select markets once it receives regulatory approval, accelerating the availability of this innovative therapy to clinicians and patients worldwide.
About EndoUVtech
EndoUVtech is a medical device company headquartered in Oakland Park, Florida, dedicated to developing advanced technologies that improve outcomes for patients suffering from ischemic stroke and other cardiovascular conditions. Founded by a team of scientists and medical industry experts, EndoUVtech focuses on UV-based therapeutic solutions that aim to reduce the side effects and enhance recovery of ischemic stroke patients. The company's flagship product, the Smart UV Laser system, is designed to minimize tissue damage and improve clot removal during endovascular procedures.
For more information, visit: [www.EndoUVtech.com]
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding potential product performance, anticipated regulatory approvals, and future market opportunities for EndoUVtech and its manufacturing partner. These statements are based on current expectations and are subject to various risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include, but are not limited to, the timing and success of regulatory submissions and approvals, market acceptance of new products, manufacturing readiness, competition, intellectual property protection, and other factors. EndoUVtech undertakes no obligation to update forward-looking statements as a result of new information, future events, or otherwise, except as required by law.
Contact
EndoUVtech
Chip Van Vurst CEO
Phone: (954) 410-9883
Email: chip@EndoUVtech.com
SOURCE: EndoUVtech
View the original press release on ACCESS Newswire
